PSME3 and Insulin resistance: AD-9308 treatment effectively reduced insulin resistance in both WT (Fig. 6c) and KI (Fig. 6d) mice and significantly improved glucose tolerance of both WT (Fig. 6e) and KI (Fig. 6f) mice in a dose-dependent manner.